ABSA International
ABSA International

Resources with keywords: Arboviruses



Risk of Severe Arboviral Disease in Patients Receiving B Cell-Depleting or Modulating Medications
CDC / Health Alert Network (HAN)
11 August 2026

State health notices documented fatal tick-borne infections across the Northeast. Rhode Island confirmed a fatal neuroinvasive Powassan virus case, marking the state’s third case in 2026. Simultaneously, Stony Brook Medicine confirmed the emergence of Bourbon virus on Long Island, transmitted by expanding Lone Star ticks (Amblyomma americanum). Bourbon virus causes acute leukopenia, thrombocytopenia, and organ failure with no commercial diagnostic assays. Laboratories performing tick identification or clinical blood analysis must operate under BSL-2 containment inside Class II Biosafety Cabinets, with tick dissection restricted to secondary containment.

CDC Issues Advisory for Dengue Fever in Mexico and 19 Other Countries—Here’s What It Means
Travel + Leisure
15 May 2025

CDC has issued a Level 1 travel advisory for individuals traveling to Brazil, Fiji, Mexico, and other countries should stay alert for the dengue disease. This disease is spread by mosquito bite and causes flu-like symptoms.

Notes from the Field: First Locally Acquired Dengue Virus Infections — Pasadena, California, October–December 2023
CDC / MMWR
1 October 2024

Feaster M, Patrick R, Oshiro M, et al.
2 cases of locally acquired Dengue investigated in Pasadena CA in late 2023.

keywords: Arboviruses, dengue
Oropouche virus: Infectious substances pathogen safety data sheet
Public Health Agency of Canada
Oropouche virus VR-266
ATCC

ATCC is a repository of biological materials. This is a sample from Trinidad.

Reemergence of Oropouche Virus in the Americas and Risk for Spread in the United States and Its Territories, 2024
CDC / Emerging Infectious Diseases
1 October 2024

Guagliardo SJ, Connelly C, Lyons S, Martin SW, Sutter R, Hughes HR, et al.
Reviews information on Oropouche virus, factors influencing its spread, transmission risk in the United States, and current status of public health response tools.

Important Information for Blood Establishments Regarding the Oropouche Virus and Blood Donation
FDA
13 September 2024

Worldwide, there have been no reports of transmission of OROV by transfusion of blood or blood components. FDA will continue to monitor cases of OROV disease in the U.S. and worldwide and will issue updated information as it becomes available.

Oropouche Virus Disease Among U.S. Travelers — United States, 2024
CDC / MMWR
5 September 2024
Oropouche virus disease - Region of the Americas
World Health Organization (WHO)
23 August 2024
Increased Oropouche Virus Activity and Associated Risk to Travelers
CDC / Health Alert Network (HAN)
16 August 2024

Includes information for travelers, Health Departments and testing laboratories.

Go to Top